Trade Summary

Yesterday, Gibson Christopher, serving as Dir at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 40,000 shares at $3.62 per share, for a total transaction value of $144,800.00. Following this transaction, Gibson Christopher now holds 883,735 shares of RXRX.

This sale represents a 4.33% decrease in Gibson Christopher's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, June 5, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 5:03 PM ET, meaning the disclosure happened on the same day as the trade.

RECURSION PHARMACEUTICALS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.